Home › Drug for relapsing forms of MS, Tecfidera approved: what's next for patients?
 

Keywords :   


Drug for relapsing forms of MS, Tecfidera approved: what's next for patients?

2013-04-22 03:58:28| Biotech - Topix.net

The third oral drug to treat relapsing remitting Multiple Sclerosis, Tecfidera, aka BG-12 from manufacturer Biogen Idec , was approved by the FDA March 27, 2013.

Tags: next forms approved drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07Cheap TVs ahead of Euros help slow price inflation
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Public Advisory Number 14A
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Atlantic Tropical Weather Outlook
02.07Eastern North Pacific Tropical Weather Outlook
02.07Murdoch Netflix rival to launch in UK
02.07Hurricane Beryl Forecast Discussion Number 14
More »